DAVID NANA ADJEI

DAVID NANA ADJEI

Medical Laboratory Sciences, University of Ghana, Accra, Greater Accra, Ghana

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DVDavid Barkolleh Vessellee
David Barkolleh Vessellee
AYakua k yalley
akua k yalley
DADAVID NANA ADJEI
DAVID NANA ADJEI
MAMark Appeaning
Mark Appeaning
POPrince Nuertey Odoom
Prince Nuertey Odoom
NNNicholas Israel Nii-Trebi
Nicholas Israel Nii-Trebi
Determination of hepatitis B virus (HBV) infections in key populations including prison inmates is crucial for formulating appropriate intervention approaches. However, in many low-income countries, such as Liberia, there is hardly any documentation on HBV prevalence among inmates. This study determined and evaluated the prevalence of HBV infections among incarcerated persons in the Monrovia Central Prison, Liberia. One hundred participants comprising 76 males and 24 females were studied. Participants’ demographic and potential risk factors information were obtained using a semi-structured questionnaire, and blood samples were collected for the analysis. Plasma was tested for five HBV serological markers, namely, HBsAg, HBsAb, HBeAg, HBeAb, and HBcAb. The seroreactivity of actively infected persons was confirmed by nucleic acid detection. Results of the serological assay showed that 34% of the participants had been exposed to the virus and 14% were actively infected. qPCR confirmed HBV DNA in seven actively infected samples. Statistical analysis indicated that a low level of education, a history of blood transfusion, and intravenous drug use, were significant predictors of active HBV infection and HBV exposure, respectively. These findings might make the testing and vaccination of convicts against HBV infection prior to their admission into prison facilities imperative.

9 June 2025 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
DODeborah Nimako Sarpong Obeng
Deborah Nimako Sarpong Obeng
SOSamuel Osei
Samuel Osei
NBNii Kpakpo Brown
Nii Kpakpo Brown
DADAVID NANA ADJEI
DAVID NANA ADJEI
LALinda Eva Amoah
Linda Eva Amoah
EOEwurama Dedea Ampadu Owusu
Ewurama Dedea Ampadu Owusu
Novel automated digital malaria diagnostic tests are being developed with the advancement of diagnostic tools. Whilst these tools are being evaluated and implemented in the general population, there is the need to focus on special populations such as individuals with Sickle Cell Disease (SCD) who have altered red blood cell morphology and atypical immune responses, which can obscure parasite detection. This study aimed to evaluate the diagnostic performance of one of such tools, the National Library of Medicine (NLM) malaria screener app in people living with sickle cell disease in a malaria-endemic country, Ghana. A descriptive cross-sectional study was conducted among SCD patients attending the Sickle Cell Clinic at Korle Bu Teaching Hospital in Accra, Ghana. Following informed consent, whole blood samples were collected and analyzed using the NLM malaria screener app, conventional microscopy, RDT, and Polymerase Chain Reaction (PCR), with PCR as the reference standard. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of each diagnostic method were compared against PCR results. The NLM app identified the highest number of positive malaria cases, with 110 positive cases (36.2%), while both RDT and microscopy reported the highest number of negatives, with 287 negative cases (94.4%). Compared to PCR, the NLM app demonstrated a sensitivity of 89.5% and a specificity of 67.4%. RDT and microscopy displayed the same sensitivity as the NLM app, each achieving 89.5%. However, while RDT and microscopy had a specificity of 100%, the NLM app had a considerably lower specificity of 67.4%.The NLM malaria screener app shows promise as a preliminary screening tool for malaria in individuals with SCD. However, its lower specificity indicates a need for confirmatory testing to avoid potential overdiagnosis and mismanagement. Enhancements in the app’s specificity could further support its utility in rapid and accessible malaria diagnosis for people with SCD, aiding in timely management and treatment.

3 September 2026 in Discover Public Health
Verified
Journal Article
Open access
PDF file
EAElizabeth Kekeli Ahiabu
Elizabeth Kekeli Ahiabu
EOEbenezer Amponsah Ofori
Ebenezer Amponsah Ofori
JFJemima Anowa Fynn
Jemima Anowa Fynn
MOMichael Olutaiwo
Michael Olutaiwo
DADAVID NANA ADJEI
DAVID NANA ADJEI
EOEwurama Dedea Ampadu Owusu
Ewurama Dedea Ampadu Owusu
Infection prevention and control (IPC) is critical in healthcare, yet the unique risks in audiology practice remain underexplored in Ghana. This study inve